Assays and other reactions involving droplets

US10221437B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10221437-B2
Application numberUS-201815884215-A
CountryUS
Kind codeB2
Filing dateJan 30, 2018
Priority dateMar 7, 2007
Publication dateMar 5, 2019
Grant dateMar 5, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention generally relates to droplets and/or emulsions, such as multiple emulsions. In some cases, the droplets and/or emulsions may be used in assays, and in certain embodiments, the droplet or emulsion may be hardened to form a gel. In some aspects, a heterogeneous assay can be performed using a gel. For example, a droplet may be hardened to form a gel, where the droplet contains a cell, DNA, or other suitable species. The gel may be exposed to a reactant, and the reactant may interact with the gel and/or with the cell, DNA, etc., in some fashion. For example, the reactant may diffuse through the gel, or the hardened particle may liquefy to form a liquid state, allowing the reactant to interact with the cell. As a specific example, DNA contained within a gel particle may be subjected to PCR (polymerase chain reaction) amplification, e.g., by using PCR primers able to bind to the gel as it forms. As the DNA is amplified using PCR, some of the DNA will be bound to the gel via the PCR primer. After the PCR reaction, unbound DNA may be removed from the gel, e.g., via diffusion or washing. Thus, a gel particle having bound DNA may be formed in one embodiment of the invention.

First claim

Opening claim text (preview).

What is claimed is: 1. A method, comprising: (a) providing a fluidic droplet in a carrying fluid, wherein said fluidic droplet comprises a first fluid that is substantially immiscible in said carrying fluid, and wherein said carrying fluid is substantially immiscible in water; (b) hardening said fluidic droplet to form a gel; (c) removing said carrying fluid; (d) placing said hardened fluidic droplet in a second fluid; and (e) subsequent to (d), containing said hardened fluidic droplet in a surrounding droplet. 2. The method of claim 1 , wherein said second fluid is immiscible in water. 3. The method of claim 1 , wherein said fluidic droplet comprises a cell. 4. The method of claim 1 , wherein said fluidic droplet comprises a nucleic acid. 5. The method of claim 1 , wherein said fluidic droplet comprises a pre-polymer and said fluidic droplet is hardened by polymerizing said pre-polymer to form said gel. 6. The method of claim 5 , wherein said fluidic droplet further comprises a polymerization initiator. 7. The method of claim 6 , wherein said fluidic droplet further comprises a polymerization accelerator. 8. The method of claim 7 , wherein said pre-polymer comprises acrylamide, said initiator comprises ammonium persulfate, or said accelerator comprises TEMED. 9. The method of claim 1 , wherein said surrounding droplet comprises a nucleic acid molecule that attaches to said gel of said hardened droplet. 10. A method, comprising: (a) providing a plurality of fluidic droplets of a first fluid in a second fluid, wherein said first fluid comprises water and said second fluid comprises a carrying fluid that is substantially immiscible with water; (b) hardening said plurality of fluidic droplets to form a plurality of hardened droplets; (c) placing said plurality of hardened droplets in a third fluid comprising a nucleic acid; (d) causing said nucleic acid in said third fluid to be contained within a hardened droplet of said plurality of hardened droplets; and (e) containing said hardened droplet within a surrounding droplet. 11. The method of claim 10 , wherein (a) comprises forming said plurality of fluidic droplets using a microfluidic device. 12. The method of claim 10 , wherein (b) comprises polymerizing said plurality of fluidic droplets into said hardened droplets. 13. The method of claim 12 , wherein said plurality of fluidic droplets comprises a pre-polymer. 14. The method of claim 13 , wherein said polymerizing comprises crosslinking said pre-polymer within said plurality of fluidic droplets. 15. The method of claim 13 , wherein said pre-polymer comprises acrylamide. 16. The method of claim 10 , further comprising separating said carrying fluid from said plurality of hardened droplets prior to (c). 17. The method of claim 10 , wherein (d) comprises attaching said nucleic acid to a polymeric component of said hardened droplet. 18. The method of claim 17 , wherein said attaching comprising covalently attaching said nucleic acid to said polymeric component of said hardened droplet. 19. The method of claim 18 , wherein said covalently attaching comprises covalently attaching said nucleic acid to said polymeric component of said hardened droplet using an acrydite moiety. 20. The method of claim 10 , wherein said nucleic acid comprises a primer sequence for conducting a nucleic acid reaction. 21. The method of claim 10 , wherein said nucleic acid comprises a sequence for conducting a polymerase chain reaction (PCR). 22. The method of claim 10 , further comprising containing said hardened droplet within said surrounding droplet using a microfluidic device. 23. The method of claim 10 , further comprising liquefying said hardened droplet within said surrounding droplet. 24. The method of claim 10 , wherein said plurality of hardened droplets is monodisperse. 25. The method of claim 24 , wherein said plurality of hardened droplets has a distribution of diameters such that no more than about 10% of said plurality of hardened droplets have an average diameter greater than about 10% of an average diameter of said plurality of hardened droplets. 26. The method of claim 10 , wherein said plurality of hardened droplets comprises a first group of hardened droplets and a second group of hardened droplets, wherein hardened droplets in said first group of hardened droplets comprise a first species and hardened droplets in said second group of hardened droplets comprise a second species, wherein said second species is different from said first species. 27. The method of claim 26 , wherein said first species is a first nucleic acid, said second species is a second nucleic acid, and said first nucleic acid has a different sequence from said second nucleic acid. 28. A method, comprising: (a) providing a fluidic droplet in a carrying fluid, wherein said fluidic droplet comprises a first fluid that is substantially immiscible in said carrying fluid, and wherein said carrying fluid is substantially immiscible in water; (b) exposing said fluidic droplet to an environmental change to harden said fluidic droplet to form a gel; (c) removing said carrying fluid; (d) placing said hardened fluidic droplet in a second fluid; and (e) subsequent to (d), containing said hardened fluidic droplet in a surrounding droplet. 29. The method of claim 28 , wherein said environmental change comprises a change in temperature. 30. The method of claim 28 , wherein said fluidic droplet comprises a nucleic acid, and wherein subsequent to (d), said hardened fluidic droplet is exposed to an additional environmental change to liquefy said gel to release said nucleic acid into said surrounding droplet. 31. The method of claim 30 , wherein said additional environmental change comprises one or more of a change in temperature, pH, or osmotic pressure. 32. The method of claim 30 , wherein said nucleic acid comprises a primer. 33. The method of claim 30 , further comprising attaching said nucleic acid to said gel. 34. The method of claim 33 , wherein said attaching comprises covalently attaching said nucleic acid to said gel. 35. The method of claim 28 , wherein (a) comprises forming said fluidic droplet using a microfluidic device. 36. The method of claim 28 , wherein said second fluid is aqueous. 37. The method of claim 28 , wherein said fluidic droplet comprises a pre-polymer and (b) comprises polymerizing said pre-polymer to form said gel. 38. The method of claim 37 , wherein said fluidic droplet further comprises a polymerization initiator. 39. The method of claim 38 , wherein said fluidic droplet further comprises a crosslinker. 40. The method of claim 10 , wherein said plurality of hardened droplets comprises a library of distinguishable entities. 41. The method of claim 40 , wherein said library of distinguishable entities are distinguishable through a species encapsulated in said plurality of hardened droplets. 42. The method of claim 10 , wherein said plurality of hardened droplets comprises a plurality of first species, wherein said third fluid comprises a plurality of second species, including said nucle

Assignees

Inventors

Classifications

  • characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction · CPC title

  • for cytology · CPC title

  • Polymerase chain reaction [PCR] · CPC title

  • specially adapted for droplet or plug flow, e.g. digital microfluidics · CPC title

  • C12P19/34Primary

    Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10221437B2 cover?
The present invention generally relates to droplets and/or emulsions, such as multiple emulsions. In some cases, the droplets and/or emulsions may be used in assays, and in certain embodiments, the droplet or emulsion may be hardened to form a gel. In some aspects, a heterogeneous assay can be performed using a gel. For example, a droplet may be hardened to form a gel, where the droplet contain…
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification C12P19/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).